Diabetes Chronic Diseases Public Health Treatment Options Weight Management Public Perception Weight Loss Economic Impact Nutrition Drug Accessibility Obesity-Related Diseases Type 2 Diabetes Cultural Attitudes Weight Loss Surgery Dietary Concerns Public Opinion Dietary Solutions Public Awareness Risk Factors Food Addiction Life Expectancy Public Health Campaigns Weight-loss Solutions Demographics Workplace Health Lifestyle Choices
The decision halts a Biden-era proposal to expand access to costly weight-loss medications, citing fiscal concerns and maintaining existing restrictions.